Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lamy

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|February 18, 2010
[UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays]P-J Lamy, G Romieu, W Jacot
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 18, 2015
[The PSA caught out]A-S Gauchez, P J Lamy, J L Descotes
British Journal of Cancer|February 18, 2010
KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?E Lopez-Crapez, L Mineur, H Emptas, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancerP J Lamy, J Grenier, A Kramar, et al.
Cellular Immunology|June 29, 2002
Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infectionB Dubois, P J Lamy, K Chemin, et al.
British Journal of Cancer|July 1, 2004
Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancerW Jacot, J-L Pujol, J-M Boher, et al.
Oncogene|October 27, 2009
Serum protein signature may improve detection of ductal carcinoma in situ of the breastJ Solassol, P Rouanet, P J Lamy, et al.
International Journal of Cancer|June 16, 2001
Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancerJ P Brouillet, M A Dujardin, D Chalbos, et al.
The International Journal of Biological Markers|May 23, 2006
Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancerP J Lamy, I Nanni, F Fina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III studyW Jacot, N Firmin, L Roca, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|February 18, 2010
[UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays]P-J Lamy, G Romieu, W Jacot
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 18, 2015
[The PSA caught out]A-S Gauchez, P J Lamy, J L Descotes
British Journal of Cancer|February 18, 2010
KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?E Lopez-Crapez, L Mineur, H Emptas, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancerP J Lamy, J Grenier, A Kramar, et al.
Cellular Immunology|June 29, 2002
Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infectionB Dubois, P J Lamy, K Chemin, et al.
British Journal of Cancer|July 1, 2004
Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancerW Jacot, J-L Pujol, J-M Boher, et al.
Oncogene|October 27, 2009
Serum protein signature may improve detection of ductal carcinoma in situ of the breastJ Solassol, P Rouanet, P J Lamy, et al.
International Journal of Cancer|June 16, 2001
Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancerJ P Brouillet, M A Dujardin, D Chalbos, et al.
The International Journal of Biological Markers|May 23, 2006
Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancerP J Lamy, I Nanni, F Fina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III studyW Jacot, N Firmin, L Roca, et al.
Pageof 2